Table 1.

Inhibitory activities of amphotericin B, fluconazole, and voriconazole against clinical isolates ofCryptococcus neoformans(n = 46) from initial cerebro-spinal fluid culture

Anti-fungal agent	Cumulative % inhibited at MIC (μg/ml)
	0.06	0.12	0.25	0.5	1	2	4	8	16	32
Amphotericin B	0	0	6.5	36.9	82.6	100
Fluconazole			0	0	0	8.7	28.3	74	95.7	100
Voriconazole	8.7	52.2	91.3	100